EL EssilorLuxottica SA

EssilorLuxottica signs an agreement to acquire Espansione Group for accelerating its growth in the med-tech space

EssilorLuxottica signs an agreement to acquire Espansione Group for accelerating its growth in the med-tech space

EssilorLuxottica signs an agreement to acquire Espansione Group

for accelerating its growth in the med-tech space

EssilorLuxottica strengthens its portfolio of advanced high-quality vision care instruments and certified medical technologies, with innovative solutions for dry-eye and other diseases



  

Paris, France (16 December 2024) – EssilorLuxottica announces that it has entered into an agreement for the acquisition of Espansione Group, an Italy-based company specialized in the design and manufacturing of non-invasive medical devices, protected by international patents, for the diagnosis and treatment of dry-eye, ocular surface and retinal diseases.

Espansione Group is a med-tech pioneer delivering the highest medical standards in over 40 countries. with the photobiomodulation (PBM) technology – the Light Modulation Low-level Light Therapy (LLLT) – for use in medical fields such as ophthalmology and dermatology, along with the Intense Pulsed Light (IPL) technology.



The agreement represents for EssilorLuxottica another step forward in the med-tech space and it is consistent with the Group’s strategy in elevating industry standards and improving the quality of patient care solutions.

Francesco Milleri, Chairman and Chief Executive Officer at EssilorLuxottica, commented: “We are pleased to welcome the pioneering Espansione into our Group. This investment, proudly made in one of our home countries, will expand our portfolio of medical devices and solidify our role in the optical industry. EssilorLuxottica’s med-tech journey, aimed at elevating vision health standards, will continue to be an open and collaborative one, where our products and services are accessible to all industry players.”

The transaction is subject to local regulatory review and other customary closing conditions.

Attachment



EN
16/12/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on EssilorLuxottica SA

 PRESS RELEASE

EssilorLuxottica: Déclaration de transactions sur actions propres

EssilorLuxottica: Déclaration de transactions sur actions propres Déclaration de transactions sur actions propres Paris, France (24 décembre 2024, 8h00) – Conformément à l’autorisation octroyée par l’Assemblée Générale du 30 avril 2024, EssilorLuxottica déclare que du 17 décembre 2024 au 23 décembre 2024 inclus, les achats d’actions propres suivants ont été réalisés : Jour de la transactionCode identifiant de l’instrument financierVolume total journalier (en nombre d’actions)Prix pondéré moyenjournalier d'acquisitiondes actions*Marché (MIC Code)17/12/2024FR000012166730 000233,7325XPAR18/1...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch